LANE BEDFORD: Open Payments
NPI 1609478015 · BELLAIRE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,149 in 67 payments from 10 companies in 2025. Trend: 2023 $495 · 2024 $969 · 2025 $1,149
Food & beverage: $1,149
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 13 | $216 |
| E.R. Squibb & Sons, L.L.C. | 13 | $186 |
| Axsome Therapeutics, Inc. | 8 | $183 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $163 |
| Lundbeck LLC | 6 | $115 |
| Otsuka America Pharmaceutical, Inc. | 5 | $103 |
| Teva Pharmaceuticals USA, Inc. | 5 | $86 |
| Janssen Pharmaceuticals, Inc | 3 | $51 |
| Alkermes, Inc. | 2 | $31 |
| ABBVIE INC. | 1 | $15 |
Products named: INGREZZA, COBENFY, Auvelity, CAPLYTA, REXULTI, UZEDY, ABILIFY MAINTENA, SPRAVATO.
Industry payments across OH — which companies pay providers there.
